Cargando…

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection

Chronic hepatitis B (CHB) is a potentially life-threatening and prevalent disease worldwide. Far from attaining the ultimate treatment goal, hepatitis B virus (HBV) infection eradication, the two current therapeutic options aim to prevent progression to end-stage liver disease, maintaining long-term...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasconcelos, Joana, Domingos, João, Bastos, Lia, Baptista, Teresa, Mansinho, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758259/ https://www.ncbi.nlm.nih.gov/pubmed/35036013 http://dx.doi.org/10.1155/2022/3890309

Ejemplares similares

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients
por: Yeh, Ming-Lun, et al.
Publicado: (2015)

Pegylated interferon alpha-2a (40 kDa) in the treatment of chronic hepatitis B
por: Lai, Lawrence, et al.
Publicado: (2006)

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
por: Scagnolari, Carolina, et al.
Publicado: (2010)

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
por: Fan, He Bin, et al.
Publicado: (2012)

Cutaneous leishmaniasis in non-endemic countries: An emerging yet neglected problem
por: Vasconcelos, Joana, et al.
Publicado: (2019)

Comparison of adefovir dipivoxil and pegylated interferon alpha-2a treatment in chronic hepatitis B patients
por: Korkmaz, Pinar, et al.
Publicado: (2014)

Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report
por: Liu, Yu, et al.
Publicado: (2022)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
por: Liu, Yisi, et al.
Publicado: (2023)

‘Double-hit’ pegylated interferon-alpha successfully treats Hepatitis B and Hepatitis D co-infection
por: Bhuva, Meha, et al.
Publicado: (2020)

Nanomedicines in the treatment of chronic hepatitis C – focus on pegylated interferon alpha-2a
por: Thomas, Thea, et al.
Publicado: (2007)

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir
por: Tamai, Hideyuki, et al.
Publicado: (2017)

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
por: Zheng, Caixia, et al.
Publicado: (2019)

Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
por: Popescu, Cristina, et al.
Publicado: (2011)

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
por: Choi, Jong Wook, et al.
Publicado: (2016)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
por: Takayama, Tetsuro, et al.
Publicado: (2011)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Campylobacter fetus Cellulitis
por: Bastos, Lia, et al.
Publicado: (2023)

Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2021)

The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B
por: He, Yi, et al.
Publicado: (2022)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
por: Huang, Yi-Wen, et al.
Publicado: (2022)

Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
por: Delicio, Adriane Maira, et al.
Publicado: (2013)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
por: Pantazis, Konstantinos D., et al.
Publicado: (2008)

Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C
por: Mimura, Imari, et al.
Publicado: (2008)

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern Slovakia
por: Drazilova, Sylvia, et al.
Publicado: (2016)

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020)

High Dose of Pegylated Interferon for the Treatment of Chronic Hepatitis B in Children Infected With Genotype C
por: Komatsu, Haruki, et al.
Publicado: (2020)

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV – focus on pegylated interferon-alpha
por: Zoller, Heinz, et al.
Publicado: (2006)

Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
por: Cho, Hyun Chin, et al.
Publicado: (2013)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
por: Carvalho-Filho, Roberto J, et al.
Publicado: (2010)

Hepatitis C Virus Clearance after Discontinuation of Pegylated Interferon Alpha-2a Monotherapy in a Child
por: Endo, Takeshi, et al.
Publicado: (2012)

The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
por: Keshvari, Maryam, et al.
Publicado: (2016)

Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B
por: Choi, Ellie, et al.
Publicado: (2018)

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
por: Younossi, Zobair M, et al.
Publicado: (2012)

The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy
por: Hu, Xiaoxia, et al.
Publicado: (2023)

Pegylated interferon/telbivudine sequential therapy in Hepatitis Be antigen negative severe chronic hepatitis B patient
por: Caroleo, Benedetto, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rfqel3mn83g53ncihnfhqgc1r0